TLOGEX Trademark

Trademark Overview

On Thursday, March 5, 2020, a trademark application was filed for TLOGEX with the United States Patent and Trademark Office. The USPTO has given the TLOGEX trademark a serial number of 88822999. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Amgen Inc.. The TLOGEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith
tlogex

General Information

Serial Number88822999
Word MarkTLOGEX
Filing DateThursday, March 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 3, 2022SOU EXTENSION 4 GRANTED
Friday, June 3, 2022SOU EXTENSION 4 FILED
Friday, June 3, 2022TEAS EXTENSION RECEIVED
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 24, 2022SOU EXTENSION 3 GRANTED
Monday, January 24, 2022SOU EXTENSION 3 FILED
Monday, January 24, 2022TEAS EXTENSION RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 2 GRANTED
Thursday, August 5, 2021SOU EXTENSION 2 FILED
Thursday, August 5, 2021TEAS EXTENSION RECEIVED
Thursday, February 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 16, 2021SOU EXTENSION 1 GRANTED
Tuesday, February 16, 2021SOU EXTENSION 1 FILED
Tuesday, February 16, 2021TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 25, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2020NEW APPLICATION ENTERED

Related Keywords

tlogex complications associated therewith disorders diseases preparations treatment oncological pharmaceutical